GlassScriptPhysician profile
Michael W Sutcliffe
NPI 1952319196
$1,359.81
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $204 · 2021: $649 · 2022: $159.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $424.69 | 2019-2022 | |
| Abbvie INC. | $328.98 | 2021-2022 | |
| Allergan, INC. | $126.84 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.16 | 2019-2022 | |
| Novo Nordisk INC | $78.24 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $50.82 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $47.46 | 2022 | |
| Merck Sharp & Dohme LLC | $41.71 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $37.40 | 2021 | |
| Ironwood Pharmaceuticals, INC | $29.16 | 2020 | |
| Pfizer INC. | $21.72 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $21.46 | 2021 | |
| Digital Diagnostics INC. | $17.46 | 2019 | |
| Lilly USA, LLC | $12.79 | 2021 | |
| Boston Scientific Corporation | $10.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sutcliffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.